Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
12.18
+0.10 (0.83%)
Dec 20, 2024, 4:00 PM EST - Market closed
Intellia Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -522.28 | -481.19 | -474.19 | -267.89 | -134.23 | -99.53 | Upgrade
|
| Depreciation & Amortization | 10.19 | 8.98 | 7.57 | 6.89 | 6.31 | 5.59 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.01 | 0.07 | -0.16 | - | 0.04 | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 55.99 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -12.01 | -19.27 | 15.41 | 10.54 | 0.54 | -3.73 | Upgrade
|
| Loss (Gain) on Equity Investments | 4.73 | 15.63 | 11.08 | 1.33 | - | - | Upgrade
|
| Stock-Based Compensation | 149.7 | 134.05 | 91.4 | 47.01 | 19.9 | 15.09 | Upgrade
|
| Other Operating Activities | - | 0.1 | 13.49 | - | - | - | Upgrade
|
| Change in Accounts Receivable | -2.36 | -32.69 | -1.74 | 0.1 | 2.49 | 2.93 | Upgrade
|
| Change in Accounts Payable | 9.31 | 2.52 | -4.58 | 0.53 | 5.06 | 1.88 | Upgrade
|
| Change in Unearned Revenue | 18.7 | -2.78 | -63.46 | -31.36 | 45.12 | -27.12 | Upgrade
|
| Change in Other Net Operating Assets | -12.69 | -19.51 | 15.91 | 7.82 | 4.86 | 1.65 | Upgrade
|
| Operating Cash Flow | -356.74 | -394.09 | -333.29 | -225.03 | -49.91 | -103.24 | Upgrade
|
| Capital Expenditures | -6.32 | -13.99 | -13.56 | -12.76 | -3.59 | -6.79 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.15 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -44.83 | - | - | - | Upgrade
|
| Investment in Securities | 26.26 | -17.36 | 218.55 | -538.02 | -210.9 | 31.97 | Upgrade
|
| Investing Cash Flow | 19.94 | -31.35 | 160.31 | -550.78 | -214.49 | 25.18 | Upgrade
|
| Issuance of Common Stock | 289.91 | 130.32 | 582.96 | 736.69 | 371.78 | 76.43 | Upgrade
|
| Financing Cash Flow | 289.91 | 130.32 | 582.96 | 736.69 | 371.78 | 76.43 | Upgrade
|
| Net Cash Flow | -46.88 | -295.11 | 409.98 | -39.12 | 107.38 | -1.63 | Upgrade
|
| Free Cash Flow | -363.06 | -408.07 | -346.85 | -237.79 | -53.5 | -110.03 | Upgrade
|
| Free Cash Flow Margin | -842.63% | -1124.94% | -665.46% | -719.41% | -92.25% | -255.28% | Upgrade
|
| Free Cash Flow Per Share | -3.78 | -4.60 | -4.51 | -3.35 | -0.96 | -2.33 | Upgrade
|
| Levered Free Cash Flow | -184.96 | -268.21 | -256.18 | -69.57 | -43.46 | -62.12 | Upgrade
|
| Unlevered Free Cash Flow | -184.96 | -268.21 | -256.18 | -69.57 | -43.46 | -62.12 | Upgrade
|
| Change in Net Working Capital | 2.46 | 75.19 | 10.41 | -56.69 | -19.28 | 9.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.